In 2012, FDA warned numerous companies that synthetic DMAA (1,3-dimethylamylamine) is not a dietary ingredient, and now state lawmakers have submitted proposals to regulate the ingredient at the state level.  For example, on January 17, 2013, New York State Senate Co-Leader Sen. Jeff Klein submitted legislation to ban sales of products containing DMAA in New York.

This proposed legislation follows recent class action settlements in lawsuits involving DMAA.  In December, USP Labs agreed to reserve $2 million for consumer redress in a class action lawsuit alleging that two of its supplements made false claims about the ingredient’s safety and effectiveness.  A class action lawsuit against GNC alleging similar claims as the one against USP has yet to be resolved.

A story in yesterday’s Guardian also noted that consumers in the UK can still purchase DMAA online even though the UK banned the sale of the ingredient four months after DMAA contributed to a marathon runner’s death at the London marathon last year.